Total Payments
$28,813
2024 Payments
$7,135
Companies
7
Transactions
29
Medicare Patients
1,135
Medicare Billing
$176,463
Payment Breakdown by Category
Consulting$24,838 (86.2%)
Food & Beverage$1,426 (4.9%)
Travel$1,300 (4.5%)
Other$1,250 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,838 | 5 | 86.2% |
| Food and Beverage | $1,426 | 16 | 4.9% |
| Travel and Lodging | $1,300 | 7 | 4.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,250 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $14,718 | 4 | $0 (2024) |
| Grifols USA, LLC | $6,892 | 6 | $0 (2024) |
| Genentech USA, Inc. | $5,272 | 5 | $0 (2020) |
| ALK-Abello, Inc | $1,460 | 5 | $0 (2021) |
| Intersect ENT, Inc. | $273.49 | 3 | $0 (2018) |
| Medtronic, Inc. | $150.92 | 4 | $0 (2024) |
| Stryker Corporation | $46.85 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,135 | 11 | Grifols USA, LLC ($6,892) |
| 2023 | $46.85 | 2 | Stryker Corporation ($46.85) |
| 2021 | $10,787 | 3 | GlaxoSmithKline, LLC. ($10,725) |
| 2020 | $9,172 | 6 | Genentech USA, Inc. ($5,272) |
| 2019 | $1,398 | 4 | ALK-Abello, Inc ($1,398) |
| 2018 | $158.45 | 2 | Intersect ENT, Inc. ($158.45) |
| 2017 | $115.04 | 1 | Intersect ENT, Inc. ($115.04) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $92.65 | General |
| 02/09/2024 | Medtronic, Inc. | FUSION (Device) | Food and Beverage | In-kind items and services | $41.77 | General |
| Category: Image Guided Surgery Products | ||||||
| 02/09/2024 | Medtronic, Inc. | FUSION (Device) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Image Guided Surgery Products | ||||||
| 02/08/2024 | Medtronic, Inc. | FUSION (Device) | Food and Beverage | In-kind items and services | $41.77 | General |
| Category: Image Guided Surgery Products | ||||||
| 02/08/2024 | Medtronic, Inc. | FUSION (Device) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Image Guided Surgery Products | ||||||
| 01/30/2024 | Grifols USA, LLC | Xembify (Biological) | Consulting Fee | Cash or cash equivalent | $5,637.50 | General |
| Category: Immunology and Neurology | ||||||
| 01/30/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | Cash or cash equivalent | $242.64 | General |
| Category: Immunology and Neurology | ||||||
| 01/25/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $328.93 | General |
| Category: Immunology and Neurology | ||||||
| 01/25/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $236.69 | General |
| Category: Immunology and Neurology | ||||||
| 01/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $50.19 | General |
| Category: Immunology and Neurology | ||||||
| 01/12/2024 | Grifols USA, LLC | Xembify (Biological) | Travel and Lodging | In-kind items and services | $395.97 | General |
| Category: Immunology and Neurology | ||||||
| 08/04/2023 | Stryker Corporation | CORE (Device) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: NEURO SPINE ENT | ||||||
| 08/04/2023 | Stryker Corporation | CORE (Device) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEURO SPINE ENT | ||||||
| 12/20/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $9,100.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2021 | ALK-Abello, Inc | Otiprio (Drug) | Food and Beverage | In-kind items and services | $62.25 | General |
| Category: Otolaryngology | ||||||
| 09/04/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2020 | Genentech USA, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $4,575.00 | General |
| Category: Immunology | ||||||
| 02/22/2020 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | In-kind items and services | $309.22 | General |
| Category: Immunology | ||||||
| 02/22/2020 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $292.62 | General |
| Category: Immunology | ||||||
| 02/22/2020 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $56.00 | General |
| Category: Immunology | ||||||
| 02/22/2020 | Genentech USA, Inc. | Xolair (Biological) | Travel and Lodging | Cash or cash equivalent | $38.70 | General |
| Category: Immunology | ||||||
| 06/09/2019 | ALK-Abello, Inc | Odactra (Drug), Ragwitek, Grastek | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Allergy and Immunology | ||||||
| 06/09/2019 | ALK-Abello, Inc | Odactra (Drug), Ragwitek, Grastek | Food and Beverage | In-kind items and services | $79.61 | General |
| Category: Allergy and Immunology | ||||||
| 06/09/2019 | ALK-Abello, Inc | Odactra (Drug), Ragwitek, Grastek | Food and Beverage | In-kind items and services | $40.75 | General |
| Category: Allergy and Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 372 | 515 | $287,481 | $60,920 |
| 2022 | 7 | 365 | 559 | $327,681 | $57,806 |
| 2021 | 8 | 253 | 393 | $279,977 | $44,175 |
| 2020 | 4 | 145 | 211 | $105,532 | $13,562 |
Total Patients
1,135
Total Services
1,678
Medicare Billing
$176,463
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 110 | 158 | $100,177 | $23,135 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 95 | $29,391 | $10,232 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $31,208 | $8,706 | 27.9% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 11 | 24 | $40,793 | $6,666 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 66 | $20,410 | $5,289 | 25.9% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Facility | 2023 | 56 | 83 | $52,624 | $4,242 | 8.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $12,879 | $2,650 | 20.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 70 | 106 | $67,207 | $16,650 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 57 | 100 | $29,922 | $7,929 | 26.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Facility | 2022 | 82 | 145 | $91,934 | $7,446 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 61 | $18,252 | $6,596 | 36.1% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Facility | 2022 | 16 | 42 | $67,599 | $6,595 | 9.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $16,347 | $4,541 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $15,356 | $3,414 | 22.2% |
| 42405 | Biopsy of saliva gland | Facility | 2022 | 11 | 11 | $11,443 | $2,195 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 16 | $6,945 | $1,803 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 14 | $2,674 | $637.38 | 23.8% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Facility | 2021 | 17 | 57 | $100,233 | $9,770 | 9.7% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 29 | 44 | $27,897 | $7,646 | 27.4% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Facility | 2021 | 62 | 110 | $69,743 | $5,825 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 32 | 55 | $16,457 | $4,260 | 25.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 31 | $13,456 | $3,873 | 28.8% |
| 42405 | Biopsy of salivary gland by incision | Facility | 2021 | 16 | 16 | $16,645 | $3,217 | 19.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 15 | $6,511 | $2,322 | 35.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 16 | 16 | $10,018 | $2,240 | 22.4% |
About Dr. Jean Kim, M.D
Dr. Jean Kim, M.D is a Otolaryngology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386685972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jean Kim, M.D has received a total of $28,813 in payments from pharmaceutical and medical device companies, with $7,135 received in 2024. These payments were reported across 29 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($24,838).
As a Medicare-enrolled provider, Kim has provided services to 1,135 Medicare beneficiaries, totaling 1,678 services with total Medicare billing of $176,463. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Baltimore, MD
- Active Since 06/08/2006
- Last Updated 02/08/2013
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1386685972
Products in Payments
- NUCALA (Biological) $14,625
- Xembify (Biological) $6,892
- Xolair (Biological) $5,272
- Odactra (Drug) $1,398
- SINUVA (Drug) $158.45
- FUSION (Device) $150.92
- PROPEL (Device) $115.04
- Otiprio (Drug) $62.25
- CORE (Device) $46.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Baltimore
Marc Dubin, M.d, M.D
Otolaryngology — Payments: $315,558
Otolaryngology $315,558
Andrew Lane, M.d, M.D
Otolaryngology — Payments: $40,413
Otolaryngology $40,413
Dr. Frank Lin, Md, MD
Otolaryngology — Payments: $32,430
Otolaryngology $32,430
Nicholas Rowan, M.d, M.D
Otolaryngology — Payments: $23,975
Otolaryngology $23,975
Dr. Rodney Taylor, M.d, M.D
Otolaryngology — Payments: $15,864
Otolaryngology $15,864
Patrick Ha, M.d, M.D
Otolaryngology — Payments: $15,560
Otolaryngology $15,560